Alt-R CRISPR-Cas9 System | Integrated DNA Technologies 株式会社
CRISPR genome editing | IDT
Recent Advancements in CRISPR Reagents
Start genome editing with CRISPR-Cas9 | IDT
Start genome editing with CRISPR-Cas9 | IDT
Start genome editing with CRISPR-Cas9 | IDT
IDT Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects without Significant Loss of On-Target Activity | Lab Manager
CRISPR GUARD Blocks Off-Target Effects with sgRNA | IDT
CRISPR Enzymes | IDT
Press Release Service: Integrated DNA Technologies Opens New Therapeutic Manufacturing Facility to Support Growing Demand in Genomic Medicine - CRISPR Medicine
Start genome editing with CRISPR-Cas9 | IDT
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells | Nature Communications
CRISPR Enzymes | IDT
Stay On-Target With Novel, High-Fidelity Cas9 | Technology Networks
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine
Start genome editing with CRISPR-Cas9 | IDT
How IDT's new HiFi Cas9 mutant is helping to overcome challenges in the clinical application of CRISPR technology | SelectScience
Reducing off-target events in CRISPR genome editing applications with a novel, high-fidelity Cas9 nuclease | PPT
CRISPR Enzymes | IDT
CRISPR-Cas9 genome editing system | IDT
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine
